An Open-study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Subjects Undergoing Surgery

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 2005

Primary Completion Date

April 30, 2006

Conditions
Haemophilia B
Interventions
BIOLOGICAL

Replenine®-VF (High Purity Factor IX)

Trial Locations (5)

125167

Haematology Centre, Russian Academy if Medical Sciences, 4a Novozykovsky Proezed., Moscow

610027

Kirov Research Institute of Haematology, 72 Krasnoarmeyskaya ul., Kirov

61-825

Samodzielny Publiczny Zaklad Opieki Zdrowotnej nad Matka I Dzieckiem, ul. Krysiewicza 7/8., Poznan

Unknown

Institutul National de Haemtologie, 2-8 Constantin Caracas Str., Bucharest

"Spitalul de urgenta pentru copii Louis Turcana, Str. losef Nemoianu 2.", Timișoara

Sponsors
All Listed Sponsors
lead

Bio Products Laboratory

OTHER